Report Detail
Global (United States, European Union and China) Antibody Drug Conjugate Market Research Report 2019-2025
- RnM3460385 |
- 27 May, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Antibody Drug Conjugate is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antibody Drug Conjugate.
This report studies the global market size of Antibody Drug Conjugate, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antibody Drug Conjugate sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited
Market Segment by Product Type
Adcetris
Kadcyl
Other
Market Segment by Application
Hospital
Pharmaceutical Company
Research Institutions
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Antibody Drug Conjugate status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antibody Drug Conjugate manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Antibody Drug Conjugate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Antibody Drug Conjugate Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Adcetris
- 1.3.3 Kadcyl
- 1.3.4 Other
- 1.4 Market Segment by Application
- 1.4.1 Global Antibody Drug Conjugate Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Pharmaceutical Company
- 1.4.4 Research Institutions
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Antibody Drug Conjugate Market Size
- 2.1.1 Global Antibody Drug Conjugate Revenue 2014-2025
- 2.1.2 Global Antibody Drug Conjugate Sales 2014-2025
- 2.2 Antibody Drug Conjugate Growth Rate by Regions
- 2.2.1 Global Antibody Drug Conjugate Sales by Regions 2014-2019
- 2.2.2 Global Antibody Drug Conjugate Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Antibody Drug Conjugate Sales by Manufacturers
- 3.1.1 Antibody Drug Conjugate Sales by Manufacturers 2014-2019
- 3.1.2 Antibody Drug Conjugate Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Antibody Drug Conjugate Revenue by Manufacturers (2014-2019)
- 3.2.2 Antibody Drug Conjugate Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Antibody Drug Conjugate Market Concentration Ratio (CR5 and HHI)
- 3.3 Antibody Drug Conjugate Price by Manufacturers
- 3.4 Key Manufacturers Antibody Drug Conjugate Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Antibody Drug Conjugate Market
- 3.6 Key Manufacturers Antibody Drug Conjugate Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Adcetris Sales and Revenue (2014-2019)
- 4.1.2 Kadcyl Sales and Revenue (2014-2019)
- 4.1.3 Other Sales and Revenue (2014-2019)
- 4.2 Global Antibody Drug Conjugate Sales Market Share by Type
- 4.3 Global Antibody Drug Conjugate Revenue Market Share by Type
- 4.4 Antibody Drug Conjugate Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Antibody Drug Conjugate Sales by Application
6 United States
- 6.1 United States Antibody Drug Conjugate Breakdown Data by Company
- 6.2 United States Antibody Drug Conjugate Breakdown Data by Type
- 6.3 United States Antibody Drug Conjugate Breakdown Data by Application
7 European Union
- 7.1 European Union Antibody Drug Conjugate Breakdown Data by Company
- 7.2 European Union Antibody Drug Conjugate Breakdown Data by Type
- 7.3 European Union Antibody Drug Conjugate Breakdown Data by Application
8 China
- 8.1 China Antibody Drug Conjugate Breakdown Data by Company
- 8.2 China Antibody Drug Conjugate Breakdown Data by Type
- 8.3 China Antibody Drug Conjugate Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Antibody Drug Conjugate Breakdown Data by Company
- 9.2 Rest of World Antibody Drug Conjugate Breakdown Data by Type
- 9.3 Rest of World Antibody Drug Conjugate Breakdown Data by Application
- 9.4 Rest of World Antibody Drug Conjugate Breakdown Data by Countries
- 9.4.1 Rest of World Antibody Drug Conjugate Sales by Countries
- 9.4.2 Rest of World Antibody Drug Conjugate Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Seattle Genetics/Takeda
- 10.1.1 Seattle Genetics/Takeda Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.1.4 Antibody Drug Conjugate Product Introduction
- 10.1.5 Seattle Genetics/Takeda Recent Development
- 10.2 Roche
- 10.2.1 Roche Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.2.4 Antibody Drug Conjugate Product Introduction
- 10.2.5 Roche Recent Development
- 10.3 ImmunoGen
- 10.3.1 ImmunoGen Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.3.4 Antibody Drug Conjugate Product Introduction
- 10.3.5 ImmunoGen Recent Development
- 10.4 Immunomedics
- 10.4.1 Immunomedics Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.4.4 Antibody Drug Conjugate Product Introduction
- 10.4.5 Immunomedics Recent Development
- 10.5 Pfizer
- 10.5.1 Pfizer Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.5.4 Antibody Drug Conjugate Product Introduction
- 10.5.5 Pfizer Recent Development
- 10.6 Celldex Therapeutics
- 10.6.1 Celldex Therapeutics Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.6.4 Antibody Drug Conjugate Product Introduction
- 10.6.5 Celldex Therapeutics Recent Development
- 10.7 Millennium Pharmaceuticals
- 10.7.1 Millennium Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.7.4 Antibody Drug Conjugate Product Introduction
- 10.7.5 Millennium Pharmaceuticals Recent Development
- 10.8 Bayer HealthCare
- 10.8.1 Bayer HealthCare Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.8.4 Antibody Drug Conjugate Product Introduction
- 10.8.5 Bayer HealthCare Recent Development
- 10.9 Mersana Therapeutics
- 10.9.1 Mersana Therapeutics Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.9.4 Antibody Drug Conjugate Product Introduction
- 10.9.5 Mersana Therapeutics Recent Development
- 10.10 Heidelberg Pharma
- 10.10.1 Heidelberg Pharma Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Antibody Drug Conjugate
- 10.10.4 Antibody Drug Conjugate Product Introduction
- 10.10.5 Heidelberg Pharma Recent Development
- 10.11 Oxford BioTherapeutics
- 10.12 Takeda Pharmaceutical Company Limited
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Antibody Drug Conjugate Sales Channels
- 11.2.2 Antibody Drug Conjugate Distributors
- 11.3 Antibody Drug Conjugate Customers
12 Market Forecast
- 12.1 Global Antibody Drug Conjugate Sales and Revenue Forecast 2019-2025
- 12.2 Global Antibody Drug Conjugate Sales Forecast by Type
- 12.3 Global Antibody Drug Conjugate Sales Forecast by Application
- 12.4 Antibody Drug Conjugate Forecast by Regions
- 12.4.1 Global Antibody Drug Conjugate Sales Forecast by Regions 2019-2025
- 12.4.2 Global Antibody Drug Conjugate Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Antibody Drug Conjugate . Industry analysis & Market Report on Antibody Drug Conjugate is a syndicated market report, published as Global (United States, European Union and China) Antibody Drug Conjugate Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Antibody Drug Conjugate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
